Thus, treatment with CRO15 induced a time-dependent phosphorylation of AMPK on multiple melanoma cell lines (Fig. 2D and Supplemental Fig. 1B) but had minimal effects on melanocytes and fibroblasts consistent with its lack of toxicity normal cells (Supplemental Fig. 1C). This evidence concerns the gene PRKAA2 and melanoma.